Minerva Neurosciences, Inc. (NERV)
2.38
-0.18
(-7.03%)
USD |
NASDAQ |
Nov 12, 16:00
Minerva Neurosciences Net Income (Annual) : -293.42M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -293.42M |
| December 31, 2024 | 1.439M |
| December 31, 2023 | -30.01M |
| December 31, 2022 | -32.11M |
| December 31, 2021 | -49.91M |
| December 31, 2020 | 1.941M |
| December 31, 2019 | -72.18M |
| December 31, 2018 | -50.17M |
| Date | Value |
|---|---|
| December 31, 2017 | -31.52M |
| December 31, 2016 | -31.05M |
| December 31, 2015 | -27.08M |
| December 31, 2014 | -56.90M |
| December 31, 2013 | -3.262M |
| December 31, 2012 | -1.582M |
| December 31, 2011 | -1.123M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Heron Therapeutics, Inc. | -20.20M |
| Tonix Pharmaceuticals Holding Corp. | -124.02M |
| Karyopharm Therapeutics, Inc. | -196.04M |
| Corbus Pharmaceuticals Holdings, Inc. | -78.54M |
| Ocugen, Inc. | -67.85M |